AstraZeneca Aktie
158,85
EUR
+0,70
EUR
+0,44
%
159,35
EUR
+0,90
EUR
+0,57
%
Werbung
AstraZeneca Aktie Analyse
| 20.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 19.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.06.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 08.06.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 08.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 01.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.05.20 | AstraZeneca overweight | Barclays Capital | |
| 14.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.05.20 | AstraZeneca overweight | Barclays Capital | |
| 01.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.04.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 27.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 23.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.04.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 17.04.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 14.04.20 | AstraZeneca buy | Deutsche Bank AG | |
| 14.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.04.20 | AstraZeneca overweight | Barclays Capital | |
| 06.04.20 | AstraZeneca buy | Deutsche Bank AG | |
| 03.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 31.03.20 | AstraZeneca buy | Deutsche Bank AG | |
| 31.03.20 | AstraZeneca buy | Oddo BHF | |
| 20.03.20 | AstraZeneca buy | Deutsche Bank AG | |
| 17.03.20 | AstraZeneca overweight | Barclays Capital | |
| 09.03.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.02.20 | AstraZeneca buy | Deutsche Bank AG | |
| 18.02.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 17.02.20 | AstraZeneca buy | Deutsche Bank AG | |
| 17.02.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 14.02.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.02.20 | AstraZeneca overweight | Barclays Capital | |
| 05.02.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 31.01.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.01.20 | AstraZeneca buy | Deutsche Bank AG | |
| 16.01.20 | AstraZeneca overweight | Barclays Capital | |
| 16.01.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 06.01.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.12.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 12.12.19 | AstraZeneca buy | Deutsche Bank AG | |
| 22.11.19 | AstraZeneca overweight | Barclays Capital | |
| 12.11.19 | AstraZeneca buy | Deutsche Bank AG | |
| 11.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 07.11.19 | AstraZeneca buy | Deutsche Bank AG | |
| 30.10.19 | AstraZeneca buy | Deutsche Bank AG | |
Werbung
Werbung